Syed O Hasan
Examiner (ID: 9396, Phone: (571)272-0990 , Office: P/3747 )
Most Active Art Unit | 3747 |
Art Unit(s) | 3783, 3747 |
Total Applications | 907 |
Issued Applications | 710 |
Pending Applications | 53 |
Abandoned Applications | 143 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16613595
[patent_doc_number] => 20210032248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => DUAL SELECTIVE PI3 DELTA AND GAMMA KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/865034
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865034
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/865034 | Dual selective PI3 delta and gamma kinase inhibitors | Apr 30, 2020 | Issued |
Array
(
[id] => 16238158
[patent_doc_number] => 20200255392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => MULTI-STAGE ESTERIFICATION PROCESS
[patent_app_type] => utility
[patent_app_number] => 16/863481
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863481 | MULTI-STAGE ESTERIFICATION PROCESS | Apr 29, 2020 | Abandoned |
Array
(
[id] => 16238157
[patent_doc_number] => 20200255391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => PROCESS FOR PRODUCING 2,5-FURANDICARBOXYLIC ACID DIALKYL ESTER
[patent_app_type] => utility
[patent_app_number] => 16/863370
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863370 | PROCESS FOR PRODUCING 2,5-FURANDICARBOXYLIC ACID DIALKYL ESTER | Apr 29, 2020 | Abandoned |
Array
(
[id] => 16374992
[patent_doc_number] => 20200323834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => HYDROPHOBIC ACID ADDITION SALTS AND PHARMACEUTICAL FORMULATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/860391
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860391 | HYDROPHOBIC ACID ADDITION SALTS AND PHARMACEUTICAL FORMULATIONS THEREOF | Apr 27, 2020 | Abandoned |
Array
(
[id] => 17913215
[patent_doc_number] => 20220315610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => USE OF IONIZATION RADIATION SOURCE IN PREPARATION OF POROUS CRYSTALLINE MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/424870
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424870
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/424870 | USE OF IONIZATION RADIATION SOURCE IN PREPARATION OF POROUS CRYSTALLINE MATERIAL | Apr 26, 2020 | Pending |
Array
(
[id] => 16398701
[patent_doc_number] => 20200339559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/858410
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858410
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858410 | Heterocyclic compounds and their use for treatment of helminthic infections and diseases | Apr 23, 2020 | Issued |
Array
(
[id] => 16511454
[patent_doc_number] => 20200390711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => CUSTOMIZABLE CANNABINOID POWDER AND PRODUCTION METHODS
[patent_app_type] => utility
[patent_app_number] => 16/852076
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16852076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/852076 | CUSTOMIZABLE CANNABINOID POWDER AND PRODUCTION METHODS | Apr 16, 2020 | Abandoned |
Array
(
[id] => 16671277
[patent_doc_number] => 20210060040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => CANNABINOID RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/849216
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849216
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849216 | Cannabinoid receptor modulators | Apr 14, 2020 | Issued |
Array
(
[id] => 16671259
[patent_doc_number] => 20210060022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/848485
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848485
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848485 | TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS | Apr 13, 2020 | Pending |
Array
(
[id] => 17611408
[patent_doc_number] => 20220153687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/442296
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/442296 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | Mar 26, 2020 | Pending |
Array
(
[id] => 16204685
[patent_doc_number] => 20200237675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Systems and Methods for Increasing Stability of Dronabinol Compositions
[patent_app_type] => utility
[patent_app_number] => 16/827079
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827079
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/827079 | Systems and methods for increasing stability of dronabinol compositions | Mar 22, 2020 | Issued |
Array
(
[id] => 16268732
[patent_doc_number] => 20200270219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => CRYSTALLINE FORMS OF (S)-AFOXOLANER
[patent_app_type] => utility
[patent_app_number] => 16/825616
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16825616
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/825616 | Crystalline forms of ( | Mar 19, 2020 | Issued |
Array
(
[id] => 16176843
[patent_doc_number] => 20200223811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT
[patent_app_type] => utility
[patent_app_number] => 16/818645
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818645
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818645 | PROCESS FOR THE PRODUCTION OF FURFURAL USING A WATER IMMISCIBLE ORGANIC SOLVENT | Mar 12, 2020 | Abandoned |
Array
(
[id] => 16111487
[patent_doc_number] => 20200207766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => INHIBITORS OF KRAS G12C AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/817109
[patent_app_country] => US
[patent_app_date] => 2020-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16817109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/817109 | Inhibitors of KRAS G12C and methods of using the same | Mar 11, 2020 | Issued |
Array
(
[id] => 16086785
[patent_doc_number] => 20200197379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS
[patent_app_type] => utility
[patent_app_number] => 16/805381
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805381
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/805381 | Composition for preventing or treating atopic dermatitis | Feb 27, 2020 | Issued |
Array
(
[id] => 16253490
[patent_doc_number] => 20200262864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => DEUTERATED FORMS OF AMINOSTEROLS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/795356
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795356 | DEUTERATED FORMS OF AMINOSTEROLS AND METHODS OF USING THE SAME | Feb 18, 2020 | Abandoned |
Array
(
[id] => 16252083
[patent_doc_number] => 20200261457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile
[patent_app_type] => utility
[patent_app_number] => 16/789976
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16789976
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/789976 | Formulations of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile | Feb 12, 2020 | Issued |
Array
(
[id] => 16236688
[patent_doc_number] => 20200253922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => METHODS FOR NON-IRRITATING PULMONARY ADMINISTRATION OF CANNABINOIDS USING SOFT MIST INHALERS
[patent_app_type] => utility
[patent_app_number] => 16/788507
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/788507 | METHODS FOR NON-IRRITATING PULMONARY ADMINISTRATION OF CANNABINOIDS USING SOFT MIST INHALERS | Feb 11, 2020 | Abandoned |
Array
(
[id] => 16221240
[patent_doc_number] => 20200246356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => NEUROSTEROIDS AND ENANTIOMERS THEREOF FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/782406
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782406
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/782406 | Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions | Feb 4, 2020 | Issued |
Array
(
[id] => 16206491
[patent_doc_number] => 20200239481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Synthetic Process and Novel Intermediates
[patent_app_type] => utility
[patent_app_number] => 16/775451
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775451
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/775451 | Synthetic process and intermediates | Jan 28, 2020 | Issued |